<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html dir="ltr" xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml">
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>

<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- 
	This website is powered by TYPO3 - inspiring people to share!
	TYPO3 is a free open source Content Management Framework initially created by Kasper Skaarhoj and licensed under GNU/GPL.
	TYPO3 is copyright 1998-2015 of Kasper Skaarhoj. Extensions are copyright of their respective owners.
	Information and contribution at http://typo3.org/
-->



<title>INHN: Lehmann Collection 6 : Heinz E. Lehmann by Edward Shorter.</title>
<meta name="generator" content="TYPO3 4.5 CMS" />

<link rel="stylesheet" type="text/css" href="IMAGES/STYLESHEET_9B1E31873F2366.CSS?1645000983" media="all" />



<script src="IMAGES/JAVASCRIPT_93077BB238F3E1.JS?1645000982" type="text/javascript"></script>


<link href="IMAGES/LAYOUT_3COL_STANDARD.CSS" rel="stylesheet" type="text/css" /><!--[if lte IE 7]><link href="fileadmin/styles/patches/../01_layouts_basics/css/patches/patch_3col_standard.css" rel="stylesheet" type="text/css" /><![endif]-->
<meta name="DC.title" content="Lehmann Collection 6 : Heinz E. Lehmann by Edward Shorter." />
<meta name="description" content="INHN" />
<meta name="DC.Description" content="INHN" />
<meta name="keywords" content="International Network for the History of Neuropsychopharmacology" />
<meta name="DC.Subject" content="International Network for the History of Neuropsychopharmacology" />
<meta name="copyright" content="Copyright INHN 2012-14" />
<meta name="DC.Rights" content="Copyright INHN 2012-14" />
<meta http-equiv="content-language" content="en" />
<meta name="DC.Language" scheme="NISOZ39.50" content="en" />
<link rev="made" href="mailto:inhn@inhn.org" />
<meta http-equiv="reply-to" content="inhn@inhn.org" />
<meta name="author" content="Gregers Wegener" />
<meta name="DC.Creator" content="Gregers Wegener" />
<meta name="rating" content="General" />
<meta name="date" content="2020-09-22T16:10:25+00:00" />
<meta name="DC.date" content="2020-09-22T16:10:25+00:00" />
<meta name="robots" content="index,follow" />
<meta name="revisit-after" content="7" />
<link rel="start" href="INDEX681A.HTM?id=1" />
<link rel="up" href="INDEX768D.HTM?id=2359" />
<link rel="next" href="INDEXB434.HTM?id=3633" />
<link rel="prev" href="INDEXEC5F.HTM?id=3616" />
<link rel="canonical" href="INDEXDB89.HTM?id=3624" />



</head>
<body id="pageUID-3624">


<div id="page_margins">
	<div id="page">
		<div id="header"><div class="tx-macinasearchbox-pi1">
		
<form action="https://inhn.org/index.php?id=5&amp;L=0" method="post" name="searchform" id="searchform">
<input name="tx_indexedsearch[sword]" type="text" value="Enter search word..." onclick="this.value=''" onblur="this.value='Enter search word...'" /><br />
<input type="hidden" name="tx_indexedsearch[_sections]" value="0" />
<input type="hidden" name="tx_indexedsearch[pointer]" value="0" />
<input type="hidden" name="tx_indexedsearch[ext]" value="0" />
<input type="hidden" name="tx_indexedsearch[lang]" value="0" />
</form>

	</div>
	<div id="topnav"><a class="skip" href="#navigation" title="Direkt zur Navigation springen">Zur Navigation springen</a><span class="hideme">.</span><a class="skip" href="#content" title="Direkt zum Content springen">Zum Content springen</a><span class="hideme">.</span><a href="INDEX3A9F.HTM?id=6" target="_self">Sitemap</a>&nbsp;&#124;&nbsp;<a href="INDEXD61C.HTM?id=5" target="_self">Search</a>&nbsp;&#124;&nbsp;<a href="INDEX65E4.HTM?id=kontakt" target="_self">Contact</a>&nbsp;&#124;&nbsp;<a href="INDEXB7B8.HTM?id=204" target="_self">About INHN</a></div><a href="INDEX2999.HTM?id=202"><img class="headImg1" src="IMAGES/COMPANY_LOGO.GIF" alt="" title="Home" width="598" height="100" /></a></div>
		<div id="nav"><a id="navigation" name="navigation"></a><div id="nav_main" class="hlist"><ul><li id="current"><a href="INDEX2999.HTM?id=202" target="_self"><span>Home</span></a></li><li><a href="INDEX7EFD.HTM?id=479" target="_self"><span>Dictionary</span></a></li><li><a href="INDEX3E5C.HTM?id=374" target="_self"><span>Drugs</span></a></li><li><a href="INDEXDBB1.HTM?id=565" target="_self"><span>Photos</span></a></li><li><a href="INDEXD919.HTM?id=342" target="_self"><span>Profiles</span></a></li><li><a href="INDEXAF9F.HTM?id=355" target="_self"><span>Controversies</span></a></li><li><a href="INDEXD122.HTM?id=641" target="_self"><span>Discoveries</span></a></li><li><a href="INDEX1F24.HTM?id=384" target="_self"><span>Books</span></a></li><li><a href="INDEX3958.HTM?id=467" target="_self"><span>Biographies</span></a></li><li><a href="INDEX677F.HTM?id=642" target="_self"><span>Perspectives</span></a></li><li><a href="INDEX8C00.HTM?id=343" target="_self"><span>Archives</span></a></li><li><a href="INDEX06CB.HTM?id=368" target="_self"><span>Ebooks</span></a></li><li><a href="INDEXA1F1.HTM?id=1755" target="_self"><span>Collated</span></a></li><li><a href="INDEXDF25.HTM?id=4128" target="_self"><span>Multilingual Project</span></a></li><li><a href="INDEXABE4.HTM?id=3884" target="_self"><span>INHN Publisher</span></a></li></ul></div></div>
		<div id="main">
			<div id="teaser" class="clearfix"><div class="rootline">You are here: <a href="INDEX2999.HTM?id=202" target="_self">Home</a>&nbsp;/&nbsp;<a href="INDEX3F39.HTM?id=1016" target="_self">Central Office (Cordoba Unit)</a>&nbsp;/&nbsp;<a href="INDEXC279.HTM?id=1659" target="_self">EDUCATION</a>&nbsp;/&nbsp;<a href="INDEX768D.HTM?id=2359" target="_self">Thomas A. Ban Neuropsychopharmacology in Historical Perspective - Education in the Field in the Post-Neuropsychopharmacology Era</a>&nbsp;/&nbsp;Lehmann Collection 6 : Heinz E. Lehmann by Edward Shorter.</div><div class="langMenu"><div class="tx-srlanguagemenu-pi1">
		
	</div>
	</div></div>
			<div id="col1">
				<div id="col1_content" class="clearfix">
					<ul id="submenu"><li id="title">Home</li><li><a href="INDEXB7B8.HTM?id=204" target="_self">About INHN</a><span class="hidden">.</span></li><li><a href="INDEXC104.HTM?id=854" target="_self">Towards education</a><span class="hidden">.</span></li><li><a href="INDEX3F39.HTM?id=1016" target="_self">Central Office (Cordoba Unit)</a><span class="hidden">.</span><ul><li><a href="INDEXEC89.HTM?id=1265" target="_self">Carlos Morra: Central Office</a></li><li><a href="INDEXF6AE.HTM?id=1234" target="_self">Administrative Unit by Leon S. Morra</a></li><li><a href="INDEXA81B.HTM?id=1233" target="_self">Carlos Morra: Chronological list of essential publications</a></li><li><a href="INDEXFC5C.HTM?id=3915" target="_self">Carlos Morra: Guide for Authors</a></li><li><a href="INDEX7A09.HTM?id=1123" target="_self">Thomas A. Ban: Recommended additions</a></li><li><a href="INDEX15CB.HTM?id=1587" target="_self">ADMINISTRATIVE UNIT</a><span class="hidden">.</span></li><li><a href="INDEXC279.HTM?id=1659" target="_self">EDUCATION</a><span class="hidden">.</span><ul><li><a href="INDEX768D.HTM?id=2359" target="_self">Thomas A. Ban Neuropsychopharmacology in Historical Perspective - Education in the Field in the Post-Neuropsychopharmacology Era</a><span class="hidden">.</span><ul><li><a href="INDEX114E.HTM?id=2360" target="_self">Bulletin 1: Educational Series 2. Jacques-Joseph Moreau de Tours.</a></li><li><a href="INDEX9E33.HTM?id=2367" target="_self">Bulletin 2 : Educational Series 2.Prologue</a></li><li><a href="INDEX1338.HTM?id=2375" target="_self">Bulletin 3 : Educational Series 2.  Vignette 1 Overview of the series: An Oral History of Neuropsychopharmacology</a></li><li><a href="INDEXF2B4.HTM?id=2385" target="_self">Bulletin 4 : Educational Series 2. Chapter 1: John Dalton’s atomic theory and drugs in psychiatry in the 19th century</a></li><li><a href="INDEXAEB2.HTM?id=2388" target="_self">Educational Series 2. Bulletin 5. Vignette 2: Sedatives in the second part of the 19th century</a></li><li><a href="INDEX8D36.HTM?id=2399" target="_self">Educational Series 2. Bulletin 6, Chapter 2: From William Cullen’s “neuroses” to Johann Christian Reil’s “psychiaterie”</a></li><li><a href="INDEX05B0.HTM?id=2404" target="_self">Educational Series 2. Bulletin 7, Vignette 3: Classifications of insanity in the late 18th and early 19th century</a></li><li><a href="INDEX525B.HTM?id=2414" target="_self">Educational Series 2. Bulletin 8, Chapter 3: Substances with an effect on consciousness</a></li><li><a href="INDEXA355.HTM?id=2422" target="_self">Educational Series 2. Bulletin 9 Vignette 4 :The isolation of morphine</a></li><li><a href="INDEX3BEE.HTM?id=2431" target="_self">Bulletin 10 : Reflexes of the brain</a></li><li><a href="INDEX8D24_2.HTM?id=2438" target="_self">Bulletin 11 : Sechenov’s re-evaluation of mental faculties and the brain</a></li><li><a href="INDEX796C.HTM?id=2451" target="_self">Bulletin 12 : Bayle’s discovery and the re-evaluation of the concept of dementia</a></li><li><a href="INDEX76A9_2.HTM?id=2458" target="_self">Bulletin 13 : Louis Sokoloff Autobiography – Regional mapping and imaging of the nervous system</a></li><li><a href="INDEXD4A9_2.HTM?id=2463" target="_self">Bulletin 14 : Joseph J. Schildkraut: Autobiography – The catecholamine hypothesis before and thereafter</a></li><li><a href="INDEXD5AC.HTM?id=2474" target="_self">Bulletin 15 : Alfred Pletscher Autobiography – On the Eve of the Birth of the Neurotransmitter Era in Biological Psychiatry</a></li><li><a href="INDEX6102.HTM?id=2483" target="_self">Bulletin 16 : Leo E. Hollister’s Interview of Julius Axelrod – The Uptake of Neurotransmitters and Psychoactive Drugs</a></li><li><a href="INDEXD4EC.HTM?id=2491" target="_self">Bulletin 17 : Thomas A. Ban’s Interview of Irwin J. Kopin – Metabolic disposition of catecholamines</a></li><li><a href="INDEXD604.HTM?id=2506" target="_self">Bulletin 18 : Thomas A. Ban’s Interview of Philip B. Bradley – Recording Electrical Activity from Cerebral Cortex and Subcortical Structures in Conscious Cats</a></li><li><a href="INDEXCD11.HTM?id=2521" target="_self">Bulletin 19 : From Conditioning and Psychiatry to Psychopharmacology*</a></li><li><a href="INDEX036F.HTM?id=2524" target="_self">Bulletin 20 : Conditioning and Psychiatry</a></li><li><a href="INDEXA67B.HTM?id=2533" target="_self">Bulletin 21 : Psychopharmacology</a></li><li><a href="INDEXA9EE_2.HTM?id=2543" target="_self">Bulletin 22 : Physiological patterns: A diagnostic test procedure based on the conditional reflex method</a></li><li><a href="INDEX8191.HTM?id=2551" target="_self">Bulletin 23 : Clinical pharmacology of psychotropic drugs</a></li><li><a href="INDEX0FE8.HTM?id=2562" target="_self">Bulletin 24 : Methodology and pitfalls in clinical testing of psychopharmacological drugs</a></li><li><a href="INDEX840B.HTM?id=2570" target="_self">Bulletin 25 : Toxicity and Adverse Reaction Studies with Neuroleptics and Antidepressants</a></li><li><a href="INDEX739E.HTM?id=2578" target="_self">Bulletin 26 : The effect of phenothiazines on the electrocardiogram</a></li><li><a href="INDEXF797.HTM?id=2586" target="_self">Bulletin 27 : Skin pigmentation, a rare side effect of chlorpromazine</a></li><li><a href="INDEX825E.HTM?id=2594" target="_self">Bulletin 28 : Ernst Feuchtersleben’s separation of psychosis from neurosis</a></li><li><a href="INDEXDC51.HTM?id=2603" target="_self">Bulletin 29 : Wilhelm Griesinger and Unitary Psychosis (Einheitpsychose)</a></li><li><a href="INDEX0C60.HTM?id=2612" target="_self">Bulletin 30 : Towards Neuropsychopharmacology in 1957</a></li><li><a href="INDEX76BD.HTM?id=2621" target="_self">Bulletin 31 : Fifty years CINP</a></li><li><a href="INDEX2103.HTM?id=2630" target="_self">Bulletin 32 : Fifty years ACNP</a></li><li><a href="INDEX6B55.HTM?id=2638" target="_self">Bulletin 33 : Starting Up (Volume One): 1. The Interviews</a></li><li><a href="INDEXEDEF.HTM?id=2647" target="_self">Bulletin 34 : Starting Up (Volume One): 2. Psychiatry</a></li><li><a href="INDEX22AE.HTM?id=2656" target="_self">Bulletin 35 : Starting Up (Volume One): 3. Drugs</a></li><li><a href="INDEXC051.HTM?id=2665" target="_self">Bulletin 36 : Starting Up (Volume One): 4. Pharmacology</a></li><li><a href="INDEX3552.HTM?id=2674" target="_self">Bulletin 37 : Starting Up (Volume One):  5. Interviewees</a></li><li><a href="INDEXBF4E.HTM?id=2683" target="_self">Bulletin 38 : Neurophysiology (Volume Two): 1. Early Development</a></li><li><a href="INDEXF887.HTM?id=2692" target="_self">Bulletin 39 : Neurophysiology (Volume Two): 2. Interviewees Contributions</a></li><li><a href="INDEX7741.HTM?id=2700" target="_self">Bulletin 40 : Neuropharmacology (Volume Three): 1. Neurotransmitters</a></li><li><a href="INDEXC58E.HTM?id=2708" target="_self">Bulletin 41 : Neuropharmacology (Volume Three): 2. Psychotropic drugs</a></li><li><a href="INDEX917B.HTM?id=2717" target="_self">Bulletin 42 : Neuropharmacology (Volume Three): 3a. Contributions of Interviewees</a></li><li><a href="INDEXBBC9.HTM?id=2726" target="_self">Bulletin 43 : Neuropharmacology (Volume Three): 3b. Contributions of Interviewees</a></li><li><a href="INDEX5AFC.HTM?id=2734" target="_self">Bulletin 44 : Psychopharmacology (Volume Four): 1. Clinical methodology</a></li><li><a href="INDEX5441.HTM?id=2751" target="_self">Bulletin 45 : Psychopharmacology (Volume Four): 2a. Contributions of Interviewees</a></li><li><a href="INDEXBB17.HTM?id=2760" target="_self">Bulletin 46 : Psychopharmacology (Volume Four): 2b. Contributions of Interviewees</a></li><li><a href="INDEX9F22.HTM?id=2761" target="_self">Bulletin 47 : Psychopharmacology (Volume Four): 2c. Contributions of Interviewees</a></li><li><a href="INDEXEFAA.HTM?id=2770" target="_self">Bulletin 48 : Neuropsychopharmacology (Volume Five): 1.Model Psychosis</a></li><li><a href="INDEX0571.HTM?id=2778" target="_self">Bulletin 49 : Neuropsychopharmacology (Volume Five): 2. Psychotoxic metabolites</a></li><li><a href="INDEX5740.HTM?id=2787" target="_self">Bulletin 50 : Neuropsychopharmacology (Volume Five): 3. Psychopharmacology of Schizophrenia; Psychopharmacology of Depression; Endocrine Measures</a></li><li><a href="INDEX47D5.HTM?id=2795" target="_self">Bulletin 51 : Neuropsychopharmacology (Volume Five): 4a. Contributions of Interviewees</a></li><li><a href="INDEXEE5A_2.HTM?id=2801" target="_self">Bulletin 52 : Neuropsychopharmacology (Volume Five): 4b. Contributions of Interviewees</a></li><li><a href="INDEX59FE.HTM?id=2810" target="_self">Bulletin 53 : Neuropsychopharmacology (Volume Five): 4c. Contributions of Interviewees</a></li><li><a href="INDEX0E71.HTM?id=2820" target="_self">Bulletin 54 : Addiction (Volume Six): 1. Addiction Psychiatry</a></li><li><a href="INDEXAE91.HTM?id=2829" target="_self">Bulletin 55 : Addiction (Volume Six): 2. Substances of abuse</a></li><li><a href="INDEX9B7D.HTM?id=2837" target="_self">Bulletin 56 : Addiction (Volume Six): 3. Conditioning and addiction</a></li><li><a href="INDEX0047_2.HTM?id=2846" target="_self">Bulletin 57 : Addiction (Volume Six): 4a. Contributions of interviewees</a></li><li><a href="INDEX44BA.HTM?id=2854" target="_self">Bulletin 58 : Addiction (Volume Six): 4b. Contributions of interviewees.</a></li><li><a href="INDEX0F23.HTM?id=2863" target="_self">Bulletin 59 : Special Areas (Volume Seven): 1. Child Psychiatry</a></li><li><a href="INDEXAA86.HTM?id=2871" target="_self">Bulletin 60 : Special Areas (Volume Seven): 2. Geriatric Psychiatry</a></li><li><a href="INDEX9ECC.HTM?id=2883" target="_self">Bulletin 61 : Special Areas (Volume Seven): 3. Psychiatric diagnosis</a></li><li><a href="INDEX1EC3.HTM?id=2892" target="_self">Bulletin 62 : Special Areas (Volume Seven): 4. Pharmacokinetics</a></li><li><a href="INDEXBAEC.HTM?id=2902" target="_self">Bulletin 63 : Special Areas (Volume Seven): 5a. Contributions of Interviewees.</a></li><li><a href="INDEX38B7.HTM?id=2921" target="_self">Bulletin 64 : Special Areas (Volume Seven): 5b. Contributions of Interviewees</a></li><li><a href="INDEX54DB.HTM?id=2938" target="_self">Bulletin 65 : Special Areas (Volume Seven): 5c. Contributions of Interviewees</a></li><li><a href="INDEX5194.HTM?id=2952" target="_self">Bulletin 66 : Diverse Topics (Volume Eight): 1. Regulation, Ethics, Marketing and Education, Conflict of Interest</a></li><li><a href="INDEXF272.HTM?id=2960" target="_self">Bulletin 67 : Diverse Topics (Volume Eight): 2a. Interviewees Contributions</a></li><li><a href="INDEXCAF4.HTM?id=2969" target="_self">Bulletin 68 : Diverse Topics (Volume Eight): 2b. Interviewees Contributions</a></li><li><a href="INDEX8272.HTM?id=2979" target="_self">Bulletin 69 : Update (Volume Nine): 1. Pharmacogenetics and Genetics and Neuropsychopharmacology</a></li><li><a href="INDEXBD8C.HTM?id=2988" target="_self">Bulletin 70 : Update (Volume Nine): 2. Psychopathology and Nosology</a></li><li><a href="INDEX2A75.HTM?id=3004" target="_self">Bulletin 71 : Update (Volume Nine): 3a. Interviewee’s Contributions</a></li><li><a href="INDEX48C2.HTM?id=3021" target="_self">Bulletin 72 : Update (Volume 9) 3b. Interviewees contributions</a></li><li><a href="INDEX616E.HTM?id=3030" target="_self">Bulletin 73 : Volume 10. Postscript</a></li><li><a href="INDEX1D4A.HTM?id=3036" target="_self">Bulletin 74 : An Overview of Developments in Psychopharmacology and Neuropsychopharmacology</a></li><li><a href="INDEX2F0A.HTM?id=3048" target="_self">Bulletin 75 : The confounding of education with marketing</a></li><li><a href="INDEX1E85.HTM?id=3055" target="_self">Bulletin 76 : Towards a genetic era in neuropsychopharmacology</a></li><li><a href="INDEX5072.HTM?id=3062" target="_self">Bulletin 77 : The CODE System</a></li><li><a href="INDEXBB3A.HTM?id=3071" target="_self">Bulletin 78 : Nosologic Homotyping</a></li><li><a href="INDEX5262.HTM?id=3085" target="_self">Collated Bulletin 1: RDoC in Historical Perspective.</a></li><li><a href="INDEX8197.HTM?id=3094" target="_self">Collated Bulletin 2 : Neuropsychopharmacology and the Forgotten Language of Psychiatry</a></li><li><a href="INDEXCB60.HTM?id=3103" target="_self">Collated Bulletin 3 : In Historical Perspective: Peralta, Cuesta and their associate’s findings on the highest familiality of Leonhard’s Classification in Polynosologic Study</a></li><li><a href="INDEX55BE.HTM?id=3111" target="_self">Collated Bulletin 4: Thomas A. Ban: The Birth of a Medical Discipline: Psychiatry</a></li><li><a href="INDEX1328.HTM?id=3124" target="_self">Collated Bulletin 5: Thomas A. Ban: Conflict of Interest in Neuropsychopharmacology. Marketing vs. Education.</a></li><li><a href="INDEX9A64.HTM?id=3130" target="_self">Collated Bulletin 6: Edward Shorter: The QT interval and the Mellaril story</a></li><li><a href="INDEXC9E3.HTM?id=3143" target="_self">Collated Bulletin 7 : Thomas A. Ban: The Wernicke – Kleist – Leonhard Tradition with Special Reference to Mania, Melancholia and Manic – Depressive Psychosis</a><span class="hidden">.</span></li><li><a href="INDEX1124.HTM?id=3152" target="_self">Collated Bulletin 8 : Thomas A. Ban: The Birth of Drug Industry and Drugs with An Effect On Behavior</a></li><li><a href="INDEX1A41.HTM?id=3164" target="_self">Collated Bulletin 9 : Thomas A. Ban: From Melancholia to Depression</a></li><li><a href="INDEX4A53.HTM?id=3170" target="_self">Collated Bulletin 10 : Thomas A. Ban: The Year 1845</a></li><li><a href="INDEX4878.HTM?id=3182" target="_self">Collated Bulletin 11 : Joseph Knoll: The discovery of monoamine oxidase (MAO) enzymes</a><span class="hidden">.</span></li><li><a href="INDEX13FE.HTM?id=3200" target="_self">Collated Bulletin 12 : Samuel Gershon: Events and Memories</a></li><li><a href="INDEXBAD0.HTM?id=3287" target="_self">Collated Bulletin 13 : Paul Devenyi: Addictions are not treatable diseases and Pharmacotherapy of addiction not a success story.</a></li><li><a href="INDEX80F0.HTM?id=3297" target="_self">Collated Bulletin 14 : Janos Radó: The use of modern antidiuretic agents in the treatment of permanent lithium-induced nephrogenic diabetes insipidus</a></li><li><a href="INDEX7FB2.HTM?id=3305" target="_self">Collated Bulletin 15 : Per Bech:  Clinical Psychometrics</a></li><li><a href="INDEX2912.HTM?id=3312" target="_self">Collated Bulletin 16 : Martin M. Katz: Onset of clinical effects of antidepressants</a></li><li><a href="INDEX412B.HTM?id=3321" target="_self">Collated Bulletin 17 : Martin M. Katz: Depression and Drugs, a monograph  and Multivantaged vs Conventional Assessment, an essay</a></li><li><a href="INDEXB116.HTM?id=3330" target="_self">Collated Bulletin 18 : Per Bech:  Measurement-based care in mental disorders (New York: Springer; 2016) Foreword and Review</a></li><li><a href="INDEX8100.HTM?id=3338" target="_self">Collated Bulletin 19 : Donald F. Klein and John Davis: Diagnosis and Drug Treatment of Mental Disorders and Thomas A. Ban: Psychopharmacology in 1969</a></li><li><a href="INDEX7B0A.HTM?id=3345" target="_self">Collated Bulletin 20 : Thomas A. Ban: Schizophrenia in the Early 1970s</a></li><li><a href="INDEXAF2B.HTM?id=3355" target="_self">Collated Bulletin 21 : Thomas A. Ban, Marcelo Cetkovich-Bakmas, Ernst Franzek and Hector Warnes: Carl Wernicke’s “elementary symptoms” and “sejunction hypothesis”</a></li><li><a href="INDEXE783.HTM?id=3374" target="_self">Collated Bulletin 22 : Martin M. Katz: Clinical Trials of Antidepressants: How Changing the Model Can Uncover New, More Effective Molecules</a></li><li><a href="INDEX4AF0.HTM?id=3393" target="_self">Collated Bulletin 23 : Joseph Knoll: From the Theory of Active Reflexes to a Neurochemical Concept of Innate and Acquired Drive</a></li><li><a href="INDEXC922.HTM?id=3401" target="_self">Collated Bulletin 24 : Ildiko Miklya: The  History of Selegiline (-) Deprenyl the First Selective Inhibitor of B-Type Monoamine Oxidase and the First Synthetic Catecholaminergic Enhancer Substance</a></li><li><a href="INDEX5549.HTM?id=3411" target="_self">Collated Bulletin 25 : Joseph Knoll: The Discovery of the Enhancer Regulation in the Mammalian Brain and the Development of the Synthetic Enhancer Substances</a></li><li><a href="INDEXBEF3.HTM?id=3421" target="_self">Collated Bulletin 26 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology: Julius Axelrod, Frank Ayd, Frank Berger, Hans Berger and Hermann Blaschko</a></li><li><a href="INDEXDEB4.HTM?id=3428" target="_self">Collated Bulletin 27 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Charles Bradley, Philip B. Bradley, Bernard B. Brodie, John Cade and John Delay</a></li><li><a href="INDEX65AD.HTM?id=3436" target="_self">Collated Bulletin 28 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Edmundo Fischer, W. Horsley Gantt, Turan M. Itil, Hitoshi Itoh and Paul Kielholz</a></li><li><a href="INDEX9D53.HTM?id=3446" target="_self">Collated Bulletin 29 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Nathan S. Kline, Roland Kuhn, Heinz E. Lehmann, Laszlo Meduna and Dionisio Nieto Gomez</a></li><li><a href="INDEX05ED.HTM?id=3454" target="_self">Collated Bulletin 30 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Alfred Pletscher, Juri Saarma, Sydney Spector, Leo Sternbach, Edward Trautner and Joseph Wo</a></li><li><a href="INDEX51CB.HTM?id=3464" target="_self">Collated Bulletin 31 : Thomas A. Ban: Lithium. 1. Discovery of its therapeutic effect in psychiatry. Johan Schioldann, William T. Hammond and Carl Lange</a></li><li><a href="INDEX7AE6.HTM?id=3471" target="_self">Collated Bulletin 32 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective. 2. Introduction into treatment in psychiatry. Samuel Gershon: Profiles of John Cade and Edward Trautner</a></li><li><a href="INDEX9492.HTM?id=3479" target="_self">Collated Bulletin 33 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective. 3. Early Years. Samuel Gershon: First-Hand Accounts</a></li><li><a href="INDEX5A82.HTM?id=3489" target="_self">Collated Bulletin 34 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective</a></li><li><a href="INDEXBC82.HTM?id=3497" target="_self">Collated Bulletin 35 : Thomas A. Ban: Lithium. 4. Controversy. Barry Blackwell vs Paul Grof and Jules Angst</a></li><li><a href="INDEXE7C3.HTM?id=3506" target="_self">Collated Bulletin 36 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective 5. Turning point. Paul Grof and Johan Schioldann</a></li><li><a href="INDEXF857.HTM?id=3514" target="_self">Collated Bulletin 37 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective 6. Action. Janusz Rybakowski</a></li><li><a href="INDEX6E77.HTM?id=3523" target="_self">Collated Bulletin 38 : Thomas A. Ban: 7.  Diagnosis</a></li><li><a href="INDEX680B.HTM?id=3532" target="_self">Collated Bulletin 39 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective Dedication and Preface</a></li><li><a href="INDEX516F.HTM?id=3541" target="_self">Collated Bulletin 40 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective.</a></li><li><a href="INDEX1901.HTM?id=3550" target="_self">Collated Bulletin 41 : Peter R. Martin. Volume 1. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by Thomas A. Ban</a></li><li><a href="INDEXCA36.HTM?id=3558" target="_self">Collated Bulletin 42 : Peter R. Martin. Volume 2. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by Leo E. Hollister</a></li><li><a href="INDEXE728.HTM?id=3566" target="_self">Collated Bulletin 43 : Peter R. Martin. Volume 2. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by William E. Bunney, Jr.</a></li><li><a href="INDEX0343.HTM?id=3583" target="_self">Lehmann Collection 1 : Charles E. Cahn’s interview of Heinz E. Lehmann</a><span class="hidden">.</span></li><li><a href="INDEXAF7B.HTM?id=3591" target="_self">Lehmann Collection 2 : William E. Bunney’s interview of Heinz E. Lehmann</a></li><li><a href="INDEXC461.HTM?id=3599" target="_self">Lehmann Collection 3 : Heinz Edgar Lehmann by Barry Blackwell</a></li><li><a href="INDEXC5D4.HTM?id=3607" target="_self">Lehmann Collection 4 : Heinz Lehmann and Douglas Hospital by Charles C. Cahn</a></li><li><a href="INDEXEC5F.HTM?id=3616" target="_self">Lehmann Collection 5 : Heinz Edgar Lehmann’s research profile by Antonio E. Nardi.</a></li><li><strong>Lehmann Collection 6 : Heinz E. Lehmann by Edward Shorter.</strong></li><li><a href="INDEXB434.HTM?id=3633" target="_self">Lehmann Collection 7 : Per Bech’s comment on Heinz E. Lehmann*</a></li><li><a href="INDEX1767.HTM?id=3641" target="_self">Lehmann Collection 8 : Paul Grof’s comment on Heinz E. Lehmann. A few personal recollections</a></li><li><a href="INDEX7BD1.HTM?id=3650" target="_self">Lehmann Collection 9 : Irwin J. Kopin’s comment on Heinz E. Lehmann.</a></li><li><a href="INDEXAE03.HTM?id=3661" target="_self">Lehmann Collection 10 : Mary and Philip Seeman's comment</a></li><li><a href="INDEXDDD3.HTM?id=3680" target="_self">Lehmann Collection 11 : A Tribute to Heinz Edgar Lehmann by Hector Warnes.</a></li><li><a href="INDEX42F1.HTM?id=3689" target="_self">Lehmann Collection 12 : Heinz Edgar Lehmann:  Publication</a></li><li><a href="INDEX8FD0.HTM?id=3698" target="_self">Lehmann Collection 13 :  Thomas A. Ban: My Personal Notes on Heinz Lehmann</a></li><li><a href="INDEXC658.HTM?id=3707" target="_self">Lehmann Collection 14 : Thomas A. Ban: Heinz E. Lehmann and Psychopharmacology</a></li><li><a href="INDEXB918.HTM?id=3717" target="_self">Lehmann Collection 15 : Thomas A. Ban: Towards a clinical methodology for neuropsychological research</a></li><li><a href="INDEXF57D.HTM?id=3726" target="_self">Lehmann Collection 16 : Heinz Edgar Lehmann</a></li><li><a href="INDEX1FC5.HTM?id=3734" target="_self">Lehmann Collection 17 : Heinz E. Lehmann: What is wrong with getting old?</a></li><li><a href="INDEX1A9C.HTM?id=3743" target="_self">Lehmann Collection 18 : Heinz E. Lehmann: Dreaming about Mental Health</a></li><li><a href="INDEXDC72.HTM?id=3753" target="_self">Lehmann Collection 19: Heinz E. Lehmann: Alcoholism, aggression and androgen function. Discussion of paper by Jack Mendelson</a></li><li><a href="INDEX7FE1.HTM?id=3761" target="_self">Lehmann Collection 20: Heinz E. Lehmann: Perspectives in Psychosurgery</a></li><li><a href="INDEX6E26.HTM?id=3770" target="_self">Lehmann Collection 21 : Heinz E. Lehmann: Discussion of the paper by Prof. P. Pichot:  The Treatment of Depression</a></li><li><a href="INDEX2F04.HTM?id=3778" target="_self">Lehmann Collection 22 : Heinz E. Lehmann: Harlem Valley Revisited</a></li><li><a href="INDEX8D36_2.HTM?id=3788" target="_self">Lehmann Collection 23 : Heinz E. Lehmann: Chlorpromazine: The Story of Phenothiazine Derivatives, Their Clinical Indications, the Incidence and Management of Untoward Effects and a Proposed Rational for Its Action</a></li><li><a href="INDEXC42B.HTM?id=3796" target="_self">Lehmann Collection 24 : Heinz E. Lehmann: The Anatomy of Research Funding</a></li><li><a href="INDEX7DC1.HTM?id=3804" target="_self">Lehmann Collection 25 : Program of Academic morning in honor of Dr. Heinz Lehmann</a></li><li><a href="INDEX212A.HTM?id=3814" target="_self">Lehmann Collection 26 : Heinz E. Lehmann: Types and Characteristics of Objective Measures of Psychopathology</a></li><li><a href="INDEX40D0.HTM?id=3877" target="_self">Classification of Functional Psychoses 1 : Preface and Recommended Reading</a></li><li><a href="INDEXF49C.HTM?id=3888" target="_self">Classification of Functional Psychoses 2 : Introduction</a></li><li><a href="INDEX12CF.HTM?id=3896" target="_self">Classification of Functional Psychoses 3 : ICD-9 and DSM-III</a></li><li><a href="INDEX93EE.HTM?id=3906" target="_self">Classification of Functional Psychoses 4: Classification of Mental Disorders and Psychopharmacology – Diagnostic Criteria for Research</a></li><li><a href="INDEX0CDC.HTM?id=3914" target="_self">Classification of Functional Psychoses 5: The KDK Budapest</a></li><li><a href="INDEX6A56.HTM?id=3923" target="_self">Classification of Functional Psychoses 6: One- and Two-Dimensional Diagnoses</a></li><li><a href="INDEX44FB.HTM?id=3933" target="_self">Classification of Functional Psychoses 7: Delusional Development and Delusional Psychoses</a></li><li><a href="INDEXA244.HTM?id=3942" target="_self">Classification of Functional Psychoses 8: Bayle’s Unitary Concept of Psychosis and Endogenous Psychoses</a></li><li><a href="INDEX76A8.HTM?id=3952" target="_self">Classification of Functional Psychoses 9: Affective Psychosis</a></li><li><a href="INDEXF554.HTM?id=3960" target="_self">Classification of Functional Psychoses 10: Empirical and Pragmatic Classifications of Depression</a></li><li><a href="INDEXB28B.HTM?id=3969" target="_self">Classification of Functional Psychoses 11: Schizophrenic Psychoses</a></li><li><a href="INDEXEE78.HTM?id=3977" target="_self">Classification of Functional Psychoses 12: Cycloid Psychoses</a></li><li><a href="INDEX79BA.HTM?id=3985" target="_self">Classification of Functional Psychoses 13: Conclusions</a></li><li><a href="INDEXFDAB.HTM?id=3994" target="_self">Classification of Functional Psychoses 14: References</a></li><li><a href="INDEXF3F8.HTM?id=4011" target="_self">Delcir da Costa’s comment on collating document</a></li><li><a href="INDEXFAD4.HTM?id=4030" target="_self">Dementia Differential Diagnosis 1991 : Contents</a></li><li><a href="INDEX05BB.HTM?id=4042" target="_self">Dementia Differential Diagnosis 1991 : Conceptual Development</a></li><li><a href="INDEXA331.HTM?id=4051" target="_self">Dementia Differential Diagnosis 1991 : Dementing Illnesses</a></li><li><a href="INDEXDEF5.HTM?id=4059" target="_self">Dementia Differential Diagnosis 1991 : Modified Concept</a></li><li><a href="INDEX4686.HTM?id=4068" target="_self">Dementia Differential Diagnosis 1991 : Diagnosing of Dementing Illness</a></li><li><a href="INDEXED54.HTM?id=4077" target="_self">Dementia Differential Diagnosis 1991 : References</a></li><li><a href="INDEX0D43.HTM?id=4132" target="_self">Methodology pitfalls of clinical testing of psychopharmaceutical</a></li><li><a href="INDEX9601.HTM?id=4140" target="_self">Mental health (Psychiatry) and pharmaceuticals in a historical perspective</a></li><li><a href="INDEX114D.HTM?id=4150" target="_self">Nosology in the teaching of psychiatry. Introduction</a></li><li><a href="INDEX4294.HTM?id=4158" target="_self">Towards a clinical methodology for neuropsychopharmacological research</a></li><li><a href="INDEXD825.HTM?id=4176" target="_self">Selective Drugs Versus Heterogeneous Diagnoses. Towards a New Methodology in Psychopharmacologic Research</a></li></ul></li><li><a href="INDEXC4F2.HTM?id=2324" target="_self">Per Bech: Members of the International Committee for the Prevention and Treatment of Depression in the mid-1980s</a></li><li><a href="INDEXC2D5.HTM?id=2299" target="_self">Per Bech and Wolfgang Rutz: The Story of the International Committee for the Prevention and Treatment of Depression</a></li><li><a href="INDEX9256.HTM?id=2371" target="_self">Peter R. Martin: Historical Dictionary of Addiction</a><span class="hidden">.</span></li><li><a href="INDEX527D.HTM?id=2648" target="_self">Amara McLaughlin-Harris: The Legal History of Psychoactive Drugs</a><span class="hidden">.</span></li><li><a href="INDEXFB23.HTM?id=2184" target="_self">Carlos Morra: An Educational Model in Psychiatry</a><span class="hidden">.</span></li><li><a href="INDEX9A07.HTM?id=2428" target="_self">Carlos Morra and Ernst Franzek: Psychopathological Symptoms</a><span class="hidden">.</span></li><li><a href="INDEX0793.HTM?id=3533" target="_self">Carlos Morra and Mateo Kreiker: Psychopathology</a><span class="hidden">.</span></li></ul></li></ul></li><li><a href="INDEX4710.HTM?id=3072" target="_self">INHN Publisher</a><span class="hidden">.</span></li><li><a href="INDEX7227.HTM?id=1114" target="_self">Programs</a><span class="hidden">.</span></li><li><a href="INDEXEAE0.HTM?id=1266" target="_self">Courses</a><span class="hidden">.</span></li><li><a href="INDEX86F6.HTM?id=1296" target="_self">Interviews</a><span class="hidden">.</span></li><li><a href="INDEXEF79.HTM?id=410" target="_self">Copyright Policy</a></li><li><a href="INDEX756E.HTM?id=437" target="_self">How to cite INHN</a></li><li><a href="INDEXCF6F.HTM?id=3373" target="_self">Website Table of Contents</a></li><li><a href="INDEXD254.HTM?id=2343" target="_self">Last Uploads</a></li></ul>
					
					<div class="textBelowMenu"><!--TYPO3SEARCH_begin--><!--TYPO3SEARCH_end--></div>
				</div>
			</div>
			<div id="col2">
				<div id="col2_content" class="clearfix"><!--TYPO3SEARCH_begin--><!--TYPO3SEARCH_end--></div>
			</div>
			<div id="col3">
			  <a id="content" name="content"></a>
				<div id="col3_content" class="clearfix">
					<div class="floatbox"><!--TYPO3SEARCH_begin--><!--DMAILER_SECTION_BOUNDARY_--><div id="c5419" class="csc-default"><h1><h1 style="FONT-SIZE: 23.25px; FONT-FAMILY: &quot;Trebuchet MS&quot;, Verdana, Helvetica, Arial, sans-serif; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: bold; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; FONT-STYLE: normal; TEXT-ALIGN: left; PADDING-TOP: 0px; PADDING-LEFT: 0px; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; PADDING-RIGHT: 0px; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"><span style="FONT-SIZE: 23.25px; FONT-WEIGHT: normal; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px">Thomas A. Ban<br style="FONT-SIZE: 23.26px; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" />Neuropsychopharmacology in Historical Perspective.</span></h1><h1 style="FONT-SIZE: 23.25px; FONT-FAMILY: &quot;Trebuchet MS&quot;, Verdana, Helvetica, Arial, sans-serif; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: bold; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; FONT-STYLE: normal; TEXT-ALIGN: left; PADDING-TOP: 0px; PADDING-LEFT: 0px; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; PADDING-RIGHT: 0px; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"><span style="FONT-SIZE: 23.25px; FONT-WEIGHT: normal; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px">Lehmann Collection 6</span></h1></h1>
<h1>&nbsp;</h1>
<h1>Heinz E. Lehmann by Edward Shorter*</h1>
<p>&nbsp;</p>
<p><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heinz Lehmann</i>, director of the Verdun Protestant Hospital in a suburb of Montreal and professor of psychiatry at McGill University, organized the first North American trials of chlorpromazine (Lehmann and Hanrahan 1954), <a href="INDEX_2.HTM#_edn1" name="_ednref1"><sup>[i]</sup></a>imipramine (Lehmann, Cahn and De Verteuil 1958), and the first trial in which the monoamine oxidase (MAO) inhibitor iproniazid (Marsilid) was shown to be effective (De Verteuil and Lehmann 1958). (Lehmann’s report on iproniazid appeared in January 1958, Nate Kline’s in June, though Kline gets credit for mentioning the effectiveness of iproniazid at a psychiatric meeting the previous year.) Lehmann was a trialists’ trialist.</p>
<p><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i>Heinz Edgar Lehmann was born in Berlin in 1911, the son of a Jewish father and a non-Jewish mother and gained his medical degree at the University of Berlin in 1935, two years after Hitler’s seizure of power (Shorter 2005). He interned at the Jewish General Hospital and the Martin Luther Hospital in Berlin then fled the country. Without any postgraduate training, he took a post in 1937 at the Verdun Protestant Hospital (now the Douglas Hospital), where initially he had, according to one biographer, “a caseload of 600 patients.” He said, “That was my postgraduate training in psychiatry” (Cahn 2001). From 1947 to 1966 Lehmann was clinical director of the hospital, thereafter director of medical education and consultant. He was emerited as professor of psychiatry at McGill in 1981.</p>
<p><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i>In 1958 Lehmann was joined by Thomas Ban from Budapest. Ban became the spark plug that drove forward many of the Verdun Hospital’s trials. “There’s hardly any drug, between 1952 and 1970, that we didn’t do clinical trials with,” Lehmann said in the interview*. In the late 1950s Lehmann and Ban figured among the chief trialists of NIMH’s Psychopharmacology Service Center, established in 1956. Lehmann was actually not a great believer in biological psychiatry, though he was grateful that the drugs were effective. As he remarked in the interview*, he thought there was a “physical substrate” to the psychoses but not to the neuroses. He remained his lifelong a proponent of the virtues of psychotherapy and even psychoanalysis. (He had read Freud’s works while in high school and never lost his enthusiasm for depth psychiatry.) He was skeptical of rating scales and large trials with undifferentiated diagnoses, preferring like many clinicians of his generation, such as Swiss psychiatrist Roland Kuhn (who initially discovered the effectiveness of imipramine), the close observation of individual patients. Yet in an institution such as Verdun, the patients were often very sick, and the effectiveness of the new agents lay at hand, regardless of whatever one thought of psychotherapy for what were then called “the walking wounded.”</p>
<p><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i>Lehmann was also a shrewd nosologist and came out early against the large American overdiagnosis of “schizophrenia” (Lehmann 1969). He coined in 1961 the term “antipsychotic,” a more exact description of the action of the phenothiazines and butyrophenones than “neuroleptic” (Lehmann 1961). Somewhat against his will, he said wryly, he became one of the founders of ACNP.</p>
<p>&nbsp;</p>
<p><b>References:</b></p>
<p>&nbsp;</p>
<p>Cahn CH. Heinz Edgar Lehmann, 1911–1999. Roy Soc Can Proc (6th series) 2001; 12:211–4.&nbsp;</p>
<p>De Verteuil RL, Lehmann HE. Therapeutic trial of iproniazid (Marsilid) in depressed and apathetic patients. Can Med Assoc J. 1958; 78:131–3.</p>
<p>Lehmann HE. New Drugs in Psychiatric Therapy. Canad Med Assn J, 1961; 85:1145-51.&nbsp;</p>
<p>Lehmann HE. Discussion: A renaissance of psychiatric diagnosis? Am J Psychiatry 1969; 125 (Suppl.): 43–6.&nbsp;</p>
<p>Lehmann HE, Cahn CH, De Verteuil RL. The treatment of depressive conditions with imipramine (G 22355). Can Psychiatr Assoc J. 1958; 3:155–64.&nbsp;</p>
<p>Lehmann HE, Hanrahan GE. Chlorpromazine: New inhibiting agent for psychomotor excitement and manic states. Arch Neurol Psychiatry. 1954; 71:227–37.&nbsp;</p>
<p>Shorter E. A Historical Dictionary of Psychiatry. New York: Oxford University Press; 2005, p.160–1.</p>
<p>&nbsp;</p>
<p>*Adopted from Shorter E, editor<b>, </b>Starting Up, in Ban TA, editor, An Oral History of Neuropsychopharmacology The First Fifty Years Peer Interviews, Volume One. Brentwood: American College of Neuropsychopharmacology; 2011, pp. xlviii -lxv. </p>
<p>&nbsp;</p>
<p>September 24, 2020</p></div><!--DMAILER_SECTION_BOUNDARY_END--><!--TYPO3SEARCH_end--></div>
				</div>
				<div id="ie_clearing">&nbsp;</div>
			</div>
		</div>
		<div id="footer">&copy; INHN 2012-2022 ::: INHN Central Office  · Av. Sagrada Familia Esq Nazaret · Córdoba, Córdoba X5000 · Argentina  ::: email: inhn@inhn.org</div>
	</div>
</div>





<script src="IMAGES/URCHIN.JS" type="text/javascript">
</script>
<script type="text/javascript">
_uacct = "UA-39727086-1";
urchinTracker();
</script>
</body>
</html>